Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes

NCT02450708 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT02450708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02450708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 31, 2015
Completion date
May 31, 2027
Enrollment
511 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia